← All stocks

CVS Health

CVS No buying or selling
CIK 0000064803 #141 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

24 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ROBBINS LARRY
Director
4,824,799
$450.87M
−59.6%
BROWN C DAVID II
Director
129,316
$12.08M
+6.5%
Joyner J. David
President, CEO and Chair
70,349
$6.57M
Shah Prem S
EVP and Group President
64,356
$6.01M
+192.5%
Mahoney Michael F
Director
45,701
$4.27M
+242.2%
COWHEY THOMAS F.
EVP and CFO
41,109
$3.84M
+22.9%
DEPARLE NANCY ANN
Director
34,169
$3.19M
+7.3%
Khichi Samrat S.
EVP, CPO and General Counsel
33,421
$3.12M
+43.5%
Clark James David
SVP, Cont & Chief Acct Officer
27,606
$2.58M
+243.1%
Finucane Anne A.
Director
22,747
$2.13M
−28.1%
FARAH ROGER N
Director
19,438
$1.82M
Balser Jeffrey R.
Director
15,717
$1.47M
+116.0%
SANSONE GUY P
Director
15,106
$1.41M
+145.2%
KIRBY J SCOTT
Director
14,434
$1.35M
+156.2%
CAPOZZI HEIDI B
EVP and Chief People Officer
13,108
$1.22M
AGUIRRE FERNANDO
Director
10,513
$982.42K
−69.5%
Mandadi Tilak
EVP, Chief Exp & Tech Officer
10,133
$946.91K
−5.5%
Compton-Phillips Amy
EVP, Chief Medical Officer
9,557
$893.08K
Norwalk Leslie V
Director
7,376
$689.27K
Shulman Douglas H.
Director
5,929
$554.05K
MILLON JEAN PIERRE
Director
4,514
$421.83K
+95.1%
Newman Brian
EVP, Chief Financial Officer
3,008
$281.09K
Nelson Steven H
EVP and President, Aetna
2,924
$273.24K
Gallina John E
Director
582
$54.39K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 4 Nov 2016